Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Xenon Pharmaceuticals
XENE
$6.13B
| $11.2M | ﹤0.01% |
283,541
-181,724
| -39% | -$6.62M |
|
2452
Syndax Pharmaceuticals
SNDX
$1.79B
| $11.2M | ﹤0.01% |
438,243
-129,838
| -23% | -$3.03M |
|
2453
State Street SPDR S&P Semiconductor ETF
XSD
$2.99B
| $11.1M | ﹤0.01% |
66,636
+16,624
| +33% | +$2.78M |
|
2454
CALL
Gilead Sciences
GILD
$164B
| $11.1M | ﹤0.01% |
129,600
+99,500
| +331% | +$7.88M |
|
2455
Entravision Communication
EVC
$1.08B
| $11.1M | ﹤0.01% |
2,314,918
-112,912
| -5% | -$554K |
|
2456
Coeur Mining
CDE
$17.4B
| $11.1M | ﹤0.01% |
3,306,623
+2,632,329
| +390% | +$9.35M |
|
2457
Jackson Financial
JXN
$8.98B
| $11.1M | ﹤0.01% |
318,432
-365,211
| -53% | -$12.7M |
|
2458
Sylvamo
SLVM
$1.64B
| $11.1M | ﹤0.01% |
227,978
-301,083
| -57% | -$14.5M |
|
2459
Fox Factory Holding Corp
FOXF
$845M
| $11.1M | ﹤0.01% |
121,365
+10,784
| +10% | +$1M |
|
2460
Vista Energy
VIST
$7.3B
| $11.1M | ﹤0.01% |
706,872
-39,264
| -5% | -$515K |
|
2461
CALL
Conagra Brands
CAG
$7.16B
| $11.1M | ﹤0.01% |
+285,700
| New | +$10.4M |
|
2462
Upstart Holdings
UPST
$2.95B
| $11M | ﹤0.01% |
835,431
+433,480
| +108% | +$8.38M |
|
|
SPYM
2463
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
| $11M | ﹤0.01% |
245,409
-21,151
| -8% | -$956K |
|
|
VGR
2464
DELISTED
Vector Group Ltd.
VGR
| $11M | ﹤0.01% |
930,296
+168,955
| +22% | +$1.78M |
|
2465
Embecta
EMBC
$266M
| $11M | ﹤0.01% |
436,064
-700
| -0.2% | -$21.4K |
|
2466
CALL
Citizens Financial Group
CFG
$30.6B
| $11M | ﹤0.01% |
280,000
| – | – |
|
2467
Vanda Pharmaceuticals
VNDA
$307M
| $11M | ﹤0.01% |
1,491,234
-213,680
| -13% | -$2.08M |
|
2468
CALL
Lucid Motors
LCID
$2.77B
| $11M | ﹤0.01% |
161,150
+156,650
| +3,481% | +$17.2M |
|
2469
Plexus
PLXS
$7.23B
| $11M | ﹤0.01% |
106,720
+59,124
| +124% | +$5.98M |
|
2470
Madison Square Garden
MSGS
$9.48B
| $11M | ﹤0.01% |
59,889
-14,063
| -19% | -$2.21M |
|
2471
Revolve Group
RVLV
$1.79B
| $11M | ﹤0.01% |
493,129
+318,351
| +182% | +$7.64M |
|
2472
Enanta Pharmaceuticals
ENTA
$392M
| $11M | ﹤0.01% |
235,446
+60,851
| +35% | +$2.77M |
|
2473
California Water Service
CWT
$3.06B
| $10.9M | ﹤0.01% |
180,127
+30,987
| +21% | +$1.86M |
|
2474
State Street SPDR S&P Pharmaceuticals ETF
XPH
$508M
| $10.9M | ﹤0.01% |
266,700
+130,565
| +96% | +$5.44M |
|
2475
Essential Properties Realty Trust
EPRT
$6.63B
| $10.9M | ﹤0.01% |
465,069
-342,226
| -42% | -$7.45M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.